With increasing pricing pressures, competition and drugs facing Loss Of Exclusivity (LOE), multinationals are exploring innovative promotional strategies to stay competitive.This article explores how a systematic approach to portfolio selling can be leveraged to ensure greater clinical and commercial success for multiple brands and to optimize this strategy as a core sales-enhancing tool.